
GlaxoSmithKline Pharmaceuticals Share Price
₹2,508.70 -60.4 (-2.35%)
22 Feb, 2025 21:39
Start SIP in
GLAXO
Performance
- Low
- ₹2,490
- High
- ₹2,590
- 52 Week Low
- ₹1,842
- 52 Week High
- ₹3,088
- Open Price₹2,579
- Previous Close₹2,569
- Volume206,809
Investment Returns
- Over 1 Month + 16.9%
- Over 3 Month + 5.87%
- Over 6 Month -18.06%
- Over 1 Year + 12.08%
Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!
GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 49.5
- PEG Ratio
- 0.8
- Market Cap Cr
- 42,499
- P/B Ratio
- 25.4
- Average True Range
- 129.3
- EPS
- 50.42
- Dividend Yield
- 1.8
- MACD Signal
- 29.08
- RSI
- 66.32
- MFI
- 87.73
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,508.70
-60.4
(-2.35%)

-
- Bearish Moving Average 0
-
- Bullish Moving Average 16
- 20 Day
- ₹2,238.96
- 50 Day
- ₹2,225.31
- 100 Day
- ₹2,311.47
- 200 Day
- ₹2,332.12
Resistance and Support
2529.57
- R3 2,669.13
- R2 2,629.57
- R1 2,569.13
- S1 2,469.13
- S2 2,429.57
- S3 2,369.13
GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
GlaxoSmithKline Pharmaceuticals F&O
About GlaxoSmithKline Pharmaceuticals
- NSE Symbol
- GLAXO
- BSE Symbol
- 500660
- Managing Director
- Mr. B Akshikar
- ISIN
- INE159A01016
Similar Stocks to GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals FAQs
GlaxoSmithKline Pharmaceuticals share price is ₹2,508 As on 22 February, 2025 | 21:25
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹42498.9 Cr As on 22 February, 2025 | 21:25
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 49.5 As on 22 February, 2025 | 21:25
The PB ratio of GlaxoSmithKline Pharmaceuticals is 25.4 As on 22 February, 2025 | 21:25
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.